Optimas Capital’s Eli Lilly LLY Stock Holding History

Optimas Capital’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.64M	Buy	+1,418	New	+$1.67M	2.18%	14
2025 Q3	–	Sell	-4,100	Closed	-$3.2M	–	38
2025 Q2	$3.2M	Buy	+4,100	New	+$3.19M	3.37%	9
2024 Q3	–	Sell	-10,914	Closed	-$8.25M	–	29
2024 Q2	$8.25M	Sell	10,914 -2,008	-16%	-$1.61M	9.38%	2
2024 Q1	$10.1M	Sell	12,922 -710	-5%	-$505K	8.79%	2
2023 Q4	$7.95M	Sell	13,632 -2,254	-14%	-$1.32M	7.5%	2
2023 Q3	$8.53M	Sell	15,886 -1,501	-9%	-$773K	5.86%	6
2023 Q2	$8.15M	Buy	17,387 +7,281	+72%	+$3.05M	9.42%	4
2023 Q1	$3.47M	Sell	10,106 -15,007	-60%	-$5.06M	2.91%	14
2022 Q4	$9.19M	Buy	25,113 +2,403	+11%	+$852K	9%	2
2022 Q3	$7.34M	Sell	22,710 -4,390	-16%	-$1.39M	6.19%	5
2022 Q2	$8.79M	Buy	+27,100	New	+$8.13M	10.78%	2

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Optimas Capital's LLY Position: Q3 2026 in Review

Optimas Capital opened a new position in Eli Lilly (LLY) in Q3 2026: 1,418 shares worth $1.64M. The stake represents 2.18% of the portfolio and ranks #14 among its holdings. This is a return to the name: Optimas Capital previously reported a position in LLY as recently as Q2 2025.

Optimas Capital first reported a position in LLY in Q2 2022 and has held it in 11 quarters since. The position peaked at $10.1M in Q1 2024. 3,244 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

Optimas Capital held 1,418 shares of Eli Lilly worth $1.64M as of Q3 2026.
Eli Lilly was a new Optimas Capital position in Q3 2026.
Eli Lilly made up 2.18% of Optimas Capital's portfolio in Q3 2026, its #14 holding.
Optimas Capital first reported a position in Eli Lilly in Q2 2022 and has held it in 11 quarters since.
Optimas Capital's Eli Lilly position peaked at $10.1M in Q1 2024.
3,244 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Optimas Capital's 13F filing for Q3 2026, filed 3 Nov 2026.